Carl June Awarded Tang Prize in Biopharmaceutical Science, Sees Greater Potential for AI and Immunotherapy [Exclusive Interview]
NQ Score
49/100
N1 Content Completeness
5
AI Summary (NQ-processed)
American immunologist Carl H. June has been jointly awarded the 7th Tang Prize in Biopharmaceutical Science for advancing CAR-T cell therapy into clinical cancer treatment. He expressed optimism about future breakthroughs and the role of AI in accelerating medical innovation.
AI Analysis
Frequently Asked Questions
- Q: What is the Tang Prize that Carl June received?
- A: The Tang Prize is an international award established by the Tang Prize Foundation in Taiwan, honoring achievements in biopharmaceutical science, sustainable development, sinology, and rule of law.
- Q: When was the first clinical success of CAR-T therapy?
- A: Carl June's team achieved the first successful CAR-T treatment on a leukemia patient in 2010.
- Q: How is AI related to CAR-T therapy?
- A: AI is expected to accelerate therapy design and predict side effects, advancing personalized medicine.